Ohio Admin. Code 3701:1-40-16 - Terms and conditions of licenses
(A)
(1) A
license, or any right under a license, shall not be transferred, assigned or in
any manner disposed of, either voluntarily or involuntarily, directly or
indirectly, through transfer of control of any license to any person, unless
the director finds that the transfer is in accordance with this rule and
Chapters 3701:1-46, 3701:1-48, 3701:1-49, 3701:1-52, and 3701:1-58 of the
Administrative Code. A license or any right contained therein may not be
transferred or conveyed without the written authorization of the director. If
the director approves the transfer and receives payment of the appropriate
licensing fee, a new license will be issued to the transferee.
(2) An application for transfer of license
must include:
(a) The identity, technical and
financial qualifications of the proposed transferee; and
(b) Financial assurance for decommissioning
information required by rule
3701:1-40-17 of the
Administrative Code.
(B) Each licensee shall confine possession
and use of radioactive material to the locations and purposes authorized in the
license. Preparation for shipment and transport of radioactive material shall
be in accordance with Chapter 3701:1-50 of the Administrative Code.
(C) The director may incorporate at the time
of issuance, or thereafter by appropriate rule, regulation, or order, such
additional requirements or conditions with respect to the licensee's receipt,
possession, use and transfer of radioactive material as the director deems
appropriate or necessary in order to protect the environment, protect health,
or minimize danger to life or property. The director may require such reports
and the keeping of such records, and provide for such inspections of activities
under the license as may be necessary to effectuate the purposes of Chapter
3748. of the Revised Code or rules adopted thereunder.
(D) A licensee that is required to submit an
emergency plan pursuant to rule
3701:1-40-14 of the
Administrative Code shall follow the emergency plan approved by the director.
The licensee may amend the approved plan without approval of the director
provided that the amendment does not decrease the effectiveness of the plan.
Within six months after amending the emergency plan, the licensee shall furnish
the amended plan to both the director and to affected offsite response
organizations. Any proposed amendment to the emergency plan that decreases, or
potentially decreases, the effectiveness of the approved emergency plan may not
be implemented without prior approval by the director.
(E) Each licensee preparing technetium-99m
radiopharmaceuticals from molybdenum-99/technetium-99m generators or
rubidium-82 from strontium-82/rubidium-82 generators shall test the generator
eluates for molybdenum-99 breakthrough or strontium-82 and strontium-85
contamination, respectively, in accordance with rule
3701:1-58-35 of the
Administrative Code. The licensee shall record the results of each test and
retain each record for three years after the record is made.
The licensee shall report the results of any test that
exceeds the permissible concentration listed in paragraph (A) of rule
3701:1-58-35 of the
Administrative Code at the time of generator elution, in accordance with rule
3701:1-58-105 of the
Administrative Code.
(F)
Each licensee must notify the director by certified mail within ten business
days of the commencement of a voluntary or involuntary bankruptcy petition that
has been filed by or against:
(1) The
licensee;
(2) An entity, defined in
this rule as person, estate, trust, governmental unit, and United States
trustee, controlling the licensee or listing the license or licensee as
property of the estate; or
(3) An
affiliate of the licensee defined in this rule as an entity that directly or
indirectly owns, controls, or holds with power to vote, twenty per cent or more
of the outstanding voting securities of the debtor, other than an entity that
holds such securities:
(a) In a fiduciary or
agency capacity without sole discretionary power to vote such securities;
or
(b) Solely to secure a debt, if
such entity has not in fact exercised such power to vote.
The notification shall specify the bankruptcy court in which the petition for bankruptcy was filed and the date of the filing petition.
(G) The director may, upon application
including adequate documentation by a person or by his own initiative, grant
such exemptions from the requirements of this chapter or other chapters of the
Administrative Code involving radioactive materials promulgated under Chapter
3748. of the Revised Code that are authorized by law and will not result in
undue hazard to life or property and are otherwise in the public
interest.
(H) Each portable gauge
licensee shall use a minimum of two independent physical controls that form
tangible barriers to secure portable gauges from unauthorized removal, whenever
portable gauges are not under the control and constant surveillance of the
licensee.
(I)
(1) Authorization under paragraph (I) of rule
3701:1-40-14 of the
Administrative Code to produce positron emission tomography (PET) radioactive
drugs for noncommercial transfer to medical use licensees in its consortium
does not relieve the licensee from complying with applicable United States
federal drug administration, other federal, and state requirements governing
radioactive drugs.
(2) Each
licensee authorized under paragraph (I) of rule
3701:1-40-14 of the
Administrative Code to produce PET radioactive drugs for noncommercial transfer
to medical use licensees in its consortium shall:
(a) Satisfy the labeling requirements in
paragraph (A)(4) of rule
3701:1-46-43 of the
Administrative Code for each PET radioactive drug transport radiation shield
and each syringe, vial, or other container used to hold a PET radioactive drug
intended for noncommercial distribution to members of its consortium.
(b) Possess and use instrumentation to
measure the radioactivity of the PET radioactive drugs intended for
noncommercial distribution to members of its consortium and meet the
procedural, radioactivity measurement, instrument test, instrument check, and
instrument adjustment requirements in paragraph (C) of rule
3701:1-46-43 of the
Administrative Code.
(3) A licensee that is a pharmacy authorized
under paragraph (I) of rule
3701:1-40-14 of the
Administrative Code to produce PET radioactive drugs for noncommercial transfer
to medical use licensees in its consortium shall require that any individual
that prepares PET radioactive drugs shall be:
(a) An authorized nuclear pharmacist that
meets the requirements in paragraph (B)(2) of rule
3701:1-46-43 of the
Administrative Code, or
(b) An
individual under the supervision of an authorized nuclear pharmacist as
specified in rule
3701:1-58-14 of the
Administrative Code.
(4)
A pharmacy, authorized under paragraph (I) of rule
3701:1-40-14 of the
Administrative Code to produce PET radioactive drugs for noncommercial transfer
to medical use licensees in its consortium that allows an individual to work as
an authorized nuclear pharmacist, shall meet the requirements of paragraph
(B)(5) of rule
3701:1-46-43 of the
Administrative Code.
Notes
Promulgated Under: 119.03
Statutory Authority: 3748.02
Rule Amplifies: 3748.02, 3748.04
Prior Effective Dates: 07/22/2001, 08/15/2005, 03/22/2007, 10/04/2010, 11/14/2013
State regulations are updated quarterly; we currently have two versions available. Below is a comparison between our most recent version and the prior quarterly release. More comparison features will be added as we have more versions to compare.
No prior version found.